$AMLN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMYLIN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMYLIN PHARMACEUTICALS INC. Get notifications about new insider transactions in AMYLIN PHARMACEUTICALS INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 18 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.41 | 77,695 | 2,285,010 | 21,410,837 | 21.3 M to 21.4 M (+0.36 %) |
Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.37 | 2,700 | 79,299 | 21,333,142 | 21.3 M to 21.3 M (+0.01 %) |
Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 29.30 | 27,389 | 802,498 | 14,711,227 | 14.7 M to 14.7 M (+0.19 %) |
Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 29.24 | 1,300 | 38,012 | 14,683,838 | 14.7 M to 14.7 M (+0.01 %) |
Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 29.47 | 66,913 | 1,971,926 | 14,682,538 | 14.6 M to 14.7 M (+0.46 %) |
Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 29.41 | 77,695 | 2,285,010 | 14,615,625 | 14.5 M to 14.6 M (+0.53 %) |
Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 29.37 | 2,700 | 79,299 | 14,537,930 | 14.5 M to 14.5 M (+0.02 %) |
Apr 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.09 | 82,967 | 2,496,477 | 21,330,442 | 21.2 M to 21.3 M (+0.39 %) |
Apr 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.07 | 64,970 | 1,953,648 | 21,247,475 | 21.2 M to 21.2 M (+0.31 %) |
Apr 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.97 | 6,000 | 179,820 | 21,182,505 | 21.2 M to 21.2 M (+0.03 %) |
Apr 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.80 | 137,363 | 4,093,417 | 21,176,505 | 21 M to 21.2 M (+0.65 %) |
Apr 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 30.09 | 82,967 | 2,496,477 | 14,535,230 | 14.5 M to 14.5 M (+0.57 %) |
Apr 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 30.07 | 64,970 | 1,953,648 | 14,452,263 | 14.4 M to 14.5 M (+0.45 %) |
Apr 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 29.97 | 6,000 | 179,820 | 14,387,293 | 14.4 M to 14.4 M (+0.04 %) |
Apr 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 29.80 | 137,363 | 4,093,417 | 14,381,293 | 14.2 M to 14.4 M (+0.96 %) |
Apr 09 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.05 | 208,700 | 6,271,435 | 21,039,142 | 20.8 M to 21 M (+1.00 %) |
Apr 09 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.96 | 50,000 | 1,548,000 | 20,830,442 | 20.8 M to 20.8 M (+0.24 %) |
Apr 09 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 31.52 | 50,000 | 1,576,000 | 20,780,442 | 20.7 M to 20.8 M (+0.24 %) |
Apr 09 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 30.05 | 208,700 | 6,271,435 | 14,243,930 | 14 M to 14.2 M (+1.49 %) |
Apr 09 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 30.96 | 50,000 | 1,548,000 | 14,035,230 | 14 M to 14 M (+0.36 %) |
Apr 09 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 31.52 | 50,000 | 1,576,000 | 13,985,230 | 13.9 M to 14 M (+0.36 %) |
Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 32.01 | 10,000 | 320,111 | 896,287 | 906.3 K to 896.3 K (-1.10 %) |
Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 0.00 | 605 | 0 | 7,876 | |
Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | A | 0.00 | 449 | 0 | 5,739 | |
Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | A | 0.00 | 449 | 0 | 6,412 | |
Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Director | Option Exercise | A | 0.00 | 449 | 0 | 1,484 | |
Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | A | 0.00 | 468 | 0 | 2,305 | |
Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | A | 0.00 | 663 | 0 | 4,414 | |
Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | A | 0.00 | 507 | 0 | 2,108 | |
Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | ALTMAN STEVEN R | Director | Option Exercise | A | 0.00 | 468 | 0 | 2,316 | |
Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 30.61 | 103,800 | 3,177,318 | 13,935,230 | 13.8 M to 13.9 M (+0.75 %) |
Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 30.50 | 51,200 | 1,561,600 | 13,831,430 | 13.8 M to 13.8 M (+0.37 %) |
Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.61 | 103,800 | 3,177,318 | 20,730,442 | 20.6 M to 20.7 M (+0.50 %) |
Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.50 | 51,200 | 1,561,600 | 20,626,642 | 20.6 M to 20.6 M (+0.25 %) |
Apr 01 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Grant | A | 0.00 | 201 | 0 | 201 | 0 to 201 |
Apr 01 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 32.51 | 10,000 | 325,072 | 906,287 | 916.3 K to 906.3 K (-1.09 %) |
Mar 28 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 28.10 | 118,933 | 3,342,017 | 20,575,442 | 20.5 M to 20.6 M (+0.58 %) |
Mar 28 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 28.10 | 118,933 | 3,342,017 | 13,780,230 | 13.7 M to 13.8 M (+0.87 %) |
Mar 26 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 28.08 | 31,067 | 872,361 | 20,456,509 | 20.4 M to 20.5 M (+0.15 %) |
Mar 26 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 28.03 | 10,000 | 280,300 | 20,425,442 | 20.4 M to 20.4 M (+0.05 %) |
Mar 26 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 28.61 | 90,000 | 2,574,900 | 20,415,442 | 20.3 M to 20.4 M (+0.44 %) |
Mar 20 2008 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Gift | G | 0.00 | 1,790 | 0 | 6,263 | 4.5 K to 6.3 K (+40.02 %) |
Mar 20 2008 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Gift | G | 0.00 | 1,790 | 0 | 44,579 | 46.4 K to 44.6 K (-3.86 %) |
Mar 20 2008 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Gift | G | 0.00 | 40 | 0 | 46,369 | 46.4 K to 46.4 K (-0.09 %) |
Mar 18 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 24.50 | 30,316 | 742,742 | 20,325,442 | 20.3 M to 20.3 M (+0.15 %) |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 3.28 | 4,344 | 14,253 | 0 | |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 2.91 | 1,096 | 3,185 | 0 | |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 3.28 | 163 | 535 | 0 | |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.31 | 5 | 2 | 0 | |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.31 | 5 | 2 | 126,221 | 126.2 K to 126.2 K (0.00 %) |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 3.28 | 163 | 535 | 126,216 | 126.1 K to 126.2 K (+0.13 %) |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 2.91 | 1,096 | 3,185 | 126,053 | 125 K to 126.1 K (+0.88 %) |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 3.28 | 4,344 | 14,253 | 124,957 | 120.6 K to 125 K (+3.60 %) |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | Young Joe A | Senior VP, Marketin ... | Option Exercise | A | 24.87 | 45,172 | 1,123,428 | 45,172 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | Young Joe A | Senior VP, Marketin ... | Option Exercise | A | 24.87 | 4,828 | 120,072 | 4,828 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | Option Exercise | A | 24.87 | 17,047 | 423,959 | 17,047 | ||
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | Option Exercise | A | 24.87 | 2,953 | 73,441 | 2,953 | ||
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | VP Operations | Option Exercise | A | 24.87 | 42,855 | 1,065,804 | 42,855 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | VP Operations | Option Exercise | A | 24.87 | 7,145 | 177,696 | 7,145 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | MARCHETTI ROGER | Sr VP HR & Corporat ... | Option Exercise | A | 24.87 | 56,250 | 1,398,938 | 56,250 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | MARCHETTI ROGER | Sr VP HR & Corporat ... | Option Exercise | A | 24.87 | 3,750 | 93,263 | 3,750 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | Sr VP, Legal, Corp ... | Option Exercise | A | 24.87 | 50,999 | 1,268,345 | 50,999 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | Sr VP, Legal, Corp ... | Option Exercise | A | 24.87 | 4,001 | 99,505 | 4,001 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | A | 24.87 | 60,980 | 1,516,573 | 60,980 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | A | 24.87 | 4,020 | 99,977 | 4,020 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Option Exercise | A | 24.87 | 65,980 | 1,640,923 | 65,980 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Option Exercise | A | 24.87 | 4,020 | 99,977 | 4,020 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | A | 24.87 | 65,980 | 1,640,923 | 65,980 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | A | 24.87 | 4,020 | 99,977 | 4,020 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | A | 24.87 | 37,500 | 932,625 | 37,500 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | A | 24.87 | 2,500 | 62,175 | 2,500 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | A | 24.87 | 60,980 | 1,516,573 | 60,980 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | A | 24.87 | 4,020 | 99,977 | 4,020 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | A | 24.87 | 270,980 | 6,739,273 | 270,980 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | A | 24.87 | 4,020 | 99,977 | 4,020 | |
Mar 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 26.80 | 30,000 | 804,000 | 20,295,126 | 20.3 M to 20.3 M (+0.15 %) |
Mar 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 26.51 | 3,300 | 87,483 | 20,265,126 | 20.3 M to 20.3 M (+0.02 %) |
Mar 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 26.45 | 16,700 | 441,715 | 20,261,826 | 20.2 M to 20.3 M (+0.08 %) |
Mar 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 27.40 | 25,000 | 685,000 | 20,245,126 | 20.2 M to 20.2 M (+0.12 %) |
Feb 20 2008 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 28.74 | 3,700 | 106,332 | 1,561,342 | 1.6 M to 1.6 M (-0.24 %) |
Feb 12 2008 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | M | 4.38 | 10,000 | 43,750 | 0 | |
Feb 12 2008 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Buy | M | 4.38 | 10,000 | 43,750 | 10,000 | 0 to 10 K |
Feb 07 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Option Exercise | M | 5.81 | 2,324 | 13,509 | 12,676 | |
Feb 07 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Option Exercise | M | 2.66 | 64,400 | 171,046 | 0 | |
Feb 07 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Buy | M | 2.66 | 64,400 | 171,046 | 916,164 | 851.8 K to 916.2 K (+7.56 %) |
Feb 07 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Buy | M | 5.81 | 2,324 | 13,509 | 851,764 | 849.4 K to 851.8 K (+0.27 %) |
Feb 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Director | Sell | S | 31.98 | 908 | 29,041 | 148,015 | 148.9 K to 148 K (-0.61 %) |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Grant | A | 37.00 | 40 | 1,480 | 849,440 | 849.4 K to 849.4 K (0.00 %) |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | Young Joe A | Senior VP, Marketin ... | Grant | A | 37.00 | 182 | 6,734 | 182 | 0 to 182 |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | Grant | A | 37.00 | 182 | 6,734 | 23,976 | 23.8 K to 24 K (+0.76 %) | |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | VP Operations | Grant | A | 37.00 | 182 | 6,734 | 182 | 0 to 182 |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | MARCHETTI ROGER | Sr VP HR & Corporat ... | Grant | A | 37.00 | 182 | 6,734 | 3,739 | 3.6 K to 3.7 K (+5.12 %) |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | Sr VP, Legal, Corp ... | Grant | A | 37.00 | 163 | 6,031 | 831 | 668 to 831 (+24.40 %) |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Grant | A | 37.00 | 182 | 6,734 | 120,169 | 120 K to 120.2 K (+0.15 %) |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP, Corporate De ... | Grant | A | 37.00 | 182 | 6,734 | 3,069 | 2.9 K to 3.1 K (+6.30 %) |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Grant | A | 37.00 | 182 | 6,734 | 23,753 | 23.6 K to 23.8 K (+0.77 %) |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Grant | A | 37.00 | 182 | 6,734 | 23,879 | 23.7 K to 23.9 K (+0.77 %) |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Grant | A | 37.00 | 182 | 6,734 | 13,330 | 13.1 K to 13.3 K (+1.38 %) |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Grant | A | 37.00 | 182 | 6,734 | 27,095 | 26.9 K to 27.1 K (+0.68 %) |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 32.08 | 3,700 | 118,681 | 1,555,042 | 1.6 M to 1.6 M (-0.24 %) |
Jan 24 2008 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 33.08 | 3,700 | 122,392 | 1,558,742 | 1.6 M to 1.6 M (-0.24 %) |
Jan 24 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 32.60 | 10,000 | 325,983 | 849,400 | 859.4 K to 849.4 K (-1.16 %) |
Jan 24 2008 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 2,000 | 14,375 | 24,616 | |
Jan 24 2008 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 2,000 | 14,375 | 26,963 | 25 K to 27 K (+8.01 %) |
Jan 16 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.78 | 5,256 | 4,105 | 16,344 | |
Jan 16 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 2.91 | 744 | 2,162 | 0 | |
Jan 16 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 35.42 | 744 | 26,350 | 120,037 | 120.8 K to 120 K (-0.62 %) |
Jan 16 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 2.91 | 744 | 2,162 | 120,781 | 120 K to 120.8 K (+0.62 %) |
Jan 16 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 35.42 | 5,256 | 186,151 | 120,037 | 125.3 K to 120 K (-4.19 %) |
Jan 16 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.78 | 5,256 | 4,105 | 125,293 | 120 K to 125.3 K (+4.38 %) |
Jan 14 2008 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Director | Option Exercise | A | 0.00 | 407 | 0 | 1,035 | |
Jan 14 2008 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | A | 0.00 | 425 | 0 | 1,837 | |
Jan 14 2008 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 0.00 | 549 | 0 | 7,271 | |
Jan 14 2008 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | A | 0.00 | 407 | 0 | 5,290 | |
Jan 14 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | A | 0.00 | 602 | 0 | 3,751 | |
Jan 14 2008 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | A | 0.00 | 407 | 0 | 5,963 | |
Jan 14 2008 | AMLN | AMYLIN PHARMACEUTI ... | ALTMAN STEVEN R | Director | Option Exercise | A | 0.00 | 425 | 0 | 1,848 | |
Jan 14 2008 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | A | 0.00 | 461 | 0 | 1,601 | |
Jan 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 36.67 | 10,000 | 366,681 | 860,800 | 870.8 K to 860.8 K (-1.15 %) |
Jan 09 2008 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 35.55 | 3,700 | 131,539 | 1,562,442 | 1.6 M to 1.6 M (-0.24 %) |
Jan 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 11.95 | 6,700 | 80,065 | 13,091 | |
Jan 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 37.20 | 6,700 | 249,253 | 120,037 | 126.7 K to 120 K (-5.29 %) |
Jan 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 11.95 | 6,700 | 80,065 | 126,737 | 120 K to 126.7 K (+5.58 %) |
Jan 02 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 60,000 | 0 | 870,800 | 930.8 K to 870.8 K (-6.45 %) |
Jan 02 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 1,350 | 0 | 930,800 | 932.2 K to 930.8 K (-0.14 %) |
Jan 02 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 400 | 0 | 932,150 | 932.6 K to 932.2 K (-0.04 %) |
Jan 02 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 1,350 | 0 | 932,550 | 933.9 K to 932.6 K (-0.14 %) |
Dec 26 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 38.23 | 3,700 | 141,461 | 1,566,142 | 1.6 M to 1.6 M (-0.24 %) |
Dec 21 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 9,000 | 64,688 | 26,616 | |
Dec 21 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 9,000 | 64,688 | 24,963 | 16 K to 25 K (+56.38 %) |
Dec 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 37.72 | 10,000 | 377,185 | 933,900 | 943.9 K to 933.9 K (-1.06 %) |
Dec 18 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 5.73 | 5,000 | 28,650 | 7,404 | |
Dec 18 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 38.39 | 5,000 | 191,950 | 120,037 | 125 K to 120 K (-4.00 %) |
Dec 18 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 5.73 | 5,000 | 28,650 | 125,037 | 120 K to 125 K (+4.17 %) |
Dec 12 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 5,217 | 0 | 81,030 | 86.2 K to 81 K (-6.05 %) |
Dec 12 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 5,217 | 0 | 86,247 | 91.5 K to 86.2 K (-5.70 %) |
Dec 12 2007 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Grant | A | 38.52 | 5,000 | 192,611 | 5,000 | 0 to 5 K |
Dec 12 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 39.05 | 3,700 | 144,503 | 1,569,842 | 1.6 M to 1.6 M (-0.24 %) |
Dec 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 16.54 | 2,000 | 33,080 | 28,749 | |
Dec 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 37.56 | 2,000 | 75,110 | 23,844 | 25.8 K to 23.8 K (-7.74 %) |
Dec 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 16.54 | 2,000 | 33,080 | 25,844 | 23.8 K to 25.8 K (+8.39 %) |
Dec 05 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 36.86 | 10,000 | 368,600 | 941,733 | 951.7 K to 941.7 K (-1.05 %) |
Nov 27 2007 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 39.05 | 3,700 | 144,491 | 1,573,542 | 1.6 M to 1.6 M (-0.23 %) |
Dec 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 3.28 | 6,700 | 21,983 | 163 | |
Dec 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 37.74 | 6,700 | 252,854 | 120,037 | 126.7 K to 120 K (-5.29 %) |
Dec 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 3.28 | 6,700 | 21,983 | 126,737 | 120 K to 126.7 K (+5.58 %) |
Nov 20 2007 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 38.71 | 10,000 | 387,061 | 951,733 | 961.7 K to 951.7 K (-1.04 %) |
Nov 20 2007 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | M | 14.28 | 9,445 | 134,884 | 47,606 | |
Nov 20 2007 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Buy | M | 14.28 | 9,445 | 134,884 | 47,417 | 38 K to 47.4 K (+24.87 %) |
Nov 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 18.85 | 1,000 | 18,850 | 56,089 |